/PRNewswire/ — After launching a breakthrough product to support better aging this summer called Qualia Senolytic, Neurohacker Collective’s CEO James…
About The Author
Related Posts
A Glb1-2A-mCherry reporter monitors systemic aging and predicts lifespan in middle-aged mice
November 19, 2022
Senolytics in the News
- Fighting ageing with immune checkpoint blockade
- Despite Their Scary Name, Some ‘Zombie’ Cells May Not Be All Bad
- Focus on frailty: New senolytic holds potential for sarcopenia treatment
- Progress in Emerging Alzheimer’s Therapeutics Based on Biology of Aging to be Highlighted in Session Moderated by Alzheimer’s Drug Discovery Foundation (ADDF) at 2022 Clinical Trials on Alzheimer’s Disease Conference
- Senolytic treatment shows promise in DME, wet AMD